September 2023 Issue Table Of Contents

From The Editor

• The L Word

Feature Articles

• Taking A Fresh Approach To Finance At BMS
• Biotech Veteran Pushes New Science And Regulatory Change

Companies To Watch

• Nido Biosciences

Industry Research

• Benefits Of Clinical Development Outsourcing Models

Podcast Summary

• The DEI Value Proposition

Inside The Industry

• Biotech Needs To Pay More Attention To Data-Privacy Laws
• Addressing The Uncertainties Of The IRA In Biopharma
• Leadership Pressures: Causing An Imbalanced Organization
• Leading with Authenticity
• Nurses: One Of Life Sciences’ Most Valuable Assets
• Strategic Business Pivoting For Cell & Gene Startups
• Why It’s Imperative To Improve Your Program Governance
• How Program Managers Can Help Reach Development Milestones
• To America, A New Biopharma Model

Industry Leader

• 3 Traits For Compliance Execs To Become Business Leaders
• Corporate Social Responsibility: Action Builds Community
• How To Make The RTO More Productive For Employees
• Successfully Launching Drugs In Europe On Time And On Budget

Ask The Board

• What Impact Is The Inflation Reduction Act Already Having On Biopharma Companies, And What More Can The Industry Do Going Forward?
• How Can Executives Work Through Tightened Budgets And Manage Tradeoffs While Keeping The Workforce Happy And Motivated?